Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2023 was -47.79% (a 282.32% increase compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 127.9%
- Annual Research and Development (R&D) Expenses Growth for 2022 was -17.52% (a 8242.86% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was -0.21% (a -105.72% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 3.67% (a -93.72% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2023 was -28.58% (a 60.02% increase compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -862.13% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -28.58% | -17.86% | -17.52% | 3.75% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Emergent Biosolutions Inc.
Most recent Research and Development (R&D) Expenses Growthof EBS including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -47.79% | -12.5% | – | – | – |
| 2022 | -30.6% | -20.97% | 1.84% | -11.62% | -17.52% |
| 2021 | 39.5% | -41.23% | 2.09% | 22.95% | -0.21% |
| 2020 | -5.25% | 58.05% | -25.04% | -7.38% | 3.67% |
| 2019 | 20.77% | 44.32% | 158.7% | 58.42% | 58.4% |
| 2018 | 82.37% | 63.29% | -4.08% | 42.12% | 46.61% |
| 2017 | 10.84% | -16.66% | -7.68% | -21.53% | -8.89% |
| 2016 | 379.6% | -20.45% | -31.87% | -32.58% | -10.31% |
| 2015 | 175.09% | -22.68% | 9.46% | 27.92% | 13.81% |
| 2014 | -123.81% | 52.77% | 23.53% | -1.52% | -12.68% |
| 2013 | -16.56% | 5.65% | -1.2% | 17.06% | -0.24% |
| 2012 | 22.36% | – | – | – | -3.69% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic